Veterinary canine NT-proBNP antigen/recombinant protein for your vet diagnostic test

• Customization: Available
• Type: Ivd Reagent Raw Materials
• Storage: 2-10ºC
• Model NO.: antigen
• Purity: 96%
• Delivery Time: 7-10 Days
• Application Platform: Elisa, Fla, Tubidity and Colloidal Gold
• Usage: Reagent Kits, Research
• Appearance: Liquid
• Transport Package: Bottle
• Specification: 1mg/bottle
• Trademark: Aoke Botai
• Origin: China
• HS Code: 3002130000
• Production Capacity: 500mg/Year

Product Description

Veterinary canine NT-proBNP antigen/recombinant protein for your vet diagnostic test
As an original manufacturer of antibody and antigen for IvD products, we produce and supply in bulk below antibodies for ifectous disease testsuitable for ELISA,CLIA, FIA,rapid test
Product information

NT-proBNP is protein produced in large amounts by the heart when it needs to work harder. It is a risk factor for atrial fibrillation and a marker of cardiac function used in the detection of heart failure. It can be used for both human and canine.
Purity: >95%
Storage: cool or freezer as per COA instruction
Period of validity: as per COA instruction
Transportation: with cool pack

Catalogue No.	Clone No.	Recommendation (detector-capture)
A3703	6F12	CLIA: 3A6-9E6/6F12/14A2 FIA: 3A6-2F5/6F12/14E5
A3704	9E6
A3705	14A2
A3707	3A6
A3708	2F5
A3709	14E5

Hot sale products 
Introduction of manufacturer

Wuhan Aoke Botai Biotechnology Co., Ltd., formerly founded in 2002, is a high-tech company specializing in the R & D, production and sales of in vitro diagnostic raw materials (including antigens and antibodies). At the same time, it is a high-tech company that provides customized services for all kinds of monoclonal antibodies, multi-antibodies and recombinant proteins. After decades of development, Our company has passed 15013485 and 1509001 certification, and has won honors such as Optical Valley Gazelle, 3551 talents, provincial innovative small and medium-sized enterprises and provincial "specialized special new" small and medium-sized enterprises. After years of painstaking research and development, the company has created two major technology platforms that are widely praised in the industry, namely, mouse monoclonal antibody hybrid pain platform and recombinant protein expression platform. The mouse hybridoma platform is a leader in the industry, and we are the first company in China to use a pair of monoclonal antibodies to detect hepatitis B HBeAg. The recombinant protein platforms are E. coli expression platform, Pichia pastoris expression platform, insect cell-baculovirus expression system and mammalian cell expression platform. At the same time, the company also has 8000 square meters of animal feeding base, which can fully meet the supply needs of diagnostic reagent manufacturers.

 

Our teams
 

Our certification